MRD-directed ibrutinib–venetoclax improves survival in CLL

Clinicians prefer once-weekly bortezomib for MM: survey

Average specialist out-of-pockets surge above $100

Survey results show improvement in medical training environment

New guidelines aim to improve HLH management and cut deaths

Hospital funding changes and more for Medicare welcome: AMA

MORE NEWS

more news